RSS-Feed abonnieren
DOI: 10.1055/s-0029-1241901
© Georg Thieme Verlag KG Stuttgart · New York
Diagnostik bei Fieber unklarer Genese (FUO)
Positronen-Emissions-Tomographie/Computer- tomographie (PET-CT) Diagnosis of fever of unknown origin (FUO) Positron emission tomography/computed tomography (PET-CT)Publikationsverlauf
eingereicht: 10.11.2008
akzeptiert: 29.4.2009
Publikationsdatum:
06. Oktober 2009 (online)

Zusammenfassung
Nuklearmedizinische Entzündungsszintigraphien haben sich bei der septischen Entzündungsherdsuche bewährt. Unbefriedigend bleibt aber bislang die Anwendung nuklearmedizinischer sowie radiologischer, sonographischer Verfahren bei Patienten mit Fieber unklarer Genese (FUO). Im Gegensatz zu akut entzündlichen, septischen Prozessen leiden meist ältere Patienten mit FUO öfters an okkulten Tumoren, atypischen Pneumonien, Hämatoblastosen, malignen Lymphomen etc. Neuerdings erlaubt 18 F(Fluor-18)-Fluordeoxy(i)glukose-PET (18F-FDG PET) treffsicher das Auffinden okkulter Veränderungen und aktuelle Daten zeigen, dass eine diagnostisch wertvolle Einordnung dieser Veränderungen zu verschiedenen Krankheitsentitäten möglich ist.
Summary
Nuclear medicine imaging is now well accepted for the localization of septic foci. But in patients the results of infection scintigraphy, radiology and ultrasound remain unsatisfactory in the diagnosis of fever of unknown origin (FUO). In contrast to septic infections, patients with FUO – mostly in elderly patients – tend to have such conditions as occult tumours, atypical pneumonia, hematoblastosis, malignant lymphomas. 18F(Fluor-18)-Fluordeoxyglucose-PET (18F-FDG PET) has made it possible to localize symptomatically occult changes with a high diagnostic accuracy and to achieve differentiation between benign and malignant changes.
Schlüsselwörter
Fieber unklarer Genese - FUO - Entzündungsszintigraphie - PET
Keywords
Fever of unknown origin - FUO - imaging infection - PET
Literatur
- 1 Baldwin A L, Thurston G. Mechanics of endothelial cell architecture and vascular permeability. Crit Rev Biomed Eng. 2001; 29 247-278
- 2 Barghouthi S, Everett K D, Speert D P. Nonopsonic phagocytosis of Pseudomonas aeruginosa requires facilitated transport of D-glucose by macrophages. J Immunol. 1995; 154 3420-3428
- 3 Bleeker-Rovers C P, Corstens F H. et al . Fever of unknown origin: prospective comparison of diagnostic value of (18)F-FDG PET and (111)In-granulocyte scintigraphy. Eur J Nucl Med Mol Imaging. 2004; 31 622-626
- 4 Bleeker-Rovers C P, Vos F J, Corstens F H, Oyen W J. Imaging of infectious diseases using [18F] fluorodeoxyglucose PET. Q J Nucl Med Mol Imaging. 2008; 52 17-29
- 5 Blockmans D, Knockaert D, Maes A. et al . Clinical value of [(18)F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis. 2001; 15,32 191-196
- 6 Brown R S, Wahl R L. Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study. Cancer. 1993; 72 2979-2985
- 7 Buonomo C, Treves S T. Gallium scanning in children with fever of unknown origin. Pediatr Radiol. 1993; 23 307-310
- 8 Buysschaert I, Vanderschueren S, Blockmans D. et al . Contribution of (18)fluoro-deoxyglucose positron emission tomography to the work-up of patients with fever of unknown origin. Eur J Intern Med. 2004; 15 151-156
- 9 Chakrabarti R, Jung C Y, Lee T P. et al . Changes in glucose transport and transporter isoforms during the activation of human peripheral blood lymphocytes by phytohemagglutinin. J Immunol. 1994; 152 2660-2668
- 10 Chung C J, Hicklin O A, Payan J M, Gordon L. Indium-111-labeled leukocyte scan in detection of synthetic vascular graft infection: the effect of antibiotic treatment. J Nucl Med. 1991; 32 13-15
- 11 Davies S G, Garvie N W. The role of indium-labelled leukocyte imaging in pyrexia of unknown origin. Br J Radiol. 1990; 63 850-854
- 12 Durack D T, Street A C. Fever of unknown origin--reexamined and redefined. Curr Clin Top Infect Dis. 1991; 11 35-51
- 13 Gratz S, Rennen H J, Boerman O C. et al . 99mTc-HMPAO-labeled autologous versus heterologous leukocytes for imaging infection. J Nucl Med. 2002; 43 918-924
- 14 Gratz S, Gotthardt M, Pfestroff A. et al . Exogenous cell stimulation for imaging infection. The Open Medical Imaging Journal. 2008; 2 42-48
- 15 Gratz S, Behr T M, Herrmann A. et al . Immunoscintigraphy (BW 250/183) in neonates and infants with fever of unknown origin. Nucl Med Commun. 1998; 19 1037-1045
- 16 Keidar Z, Gurman-Balbir A, Gaitini D, Israel O. Fever of Unknown Origin: The Role of 18F-FDG PET/CT. J Nucl Med. 2008; 49 1980-1985
- 17 Kelly M J, Kalff V, Hicks R J. et al . 111In-oxine labelled leukocyte scintigraphy in the detection and localization of active inflammation and sepsis. Med J Aust. 1990; 152 352-357
- 18 Knochel J Q, Koehler P R, Lee T G, Welch D M. Diagnosis of abdominal abscesses with computed tomography, ultrasound, and 111In leukocyte scans. Radiology. 1980; 137 425-432
- 19 Knockaert D C, Vanderschueren S, Blockmans D. Fever of unknown origin in adults: 40 years on. J Intern Med. 2003; 253 263-275
- 20 Kjaer A, Lebech A M, Eigtved A, Højgaard L. Fever of unknown origin: prospective comparison of diagnostic value of 18F-FDG PET and 111In-granulocyte scintigraphy. Eur J Nucl Med Mol Imaging. 2004; 31 1342-31343
- 21 Lorenzen J, Buchert R, Bohuslavizki K H. Value of FDG PET in patients with fever of unknown origin. Nucl Med Commun. 2001; 22 779-783
- 22 Majno G, Palade G E. Studies on inflammation. The effect of histamine and serotonin on vascular permeability: an electron microscopic study. J Biophys Biochem Cytol. 1961; 11 571-605
- 23 Mamede M, Higashi T, Kitaichi M. et al . [18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung. Neoplasia. 2005; 7 369-379
- 24 Meller J, Ivancevic V, Conrad M. Clinical value of immunoscintigraphy in patients with fever of unknown origin. J Nucl Med. 1998; 39 1248-1253
- 25 Meller J, Altenvoerde G, Munzel U. Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET. Eur J Nucl Med. 2000; 27 1617-1625
- 26 Peters A M. Nuclear medicine imaging in fever of unknown origin. Q J Nucl Med. 1999; 43 61-73
- 27 Petersdorf R G, Beeson P B. Fever of unexplained origin: report on 100 cases. Medicine. 1961; 40 1-30
- 28 Sørensen H T, Mellemkjaer L, Skriver M V. et al . Fever of unknown origin and cancer: a population-based study. Lancet Oncol. 2005; 6 851-855
Priv.-Doz. Dr. Dr. med. S. Gratz
Praxis für Nuklearmedizin
Seelbergstraße
11
70372 Stuttgart
Telefon: 0711/5538241
Fax: 0711/5538246
eMail: Nuklearmedizin-Gratz@gmx.net